Sun Pharma Advanced Research Company Limited Share Price
Equities
SPARC
INE232I01014
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
217.4 INR | -0.91% | +3.40% | -24.20% |
Sales 2022 | 1.37B 16.46M 1.3B | Sales 2023 | 2.39B 28.63M 2.26B | Capitalization | 58.2B 698M 55.05B |
---|---|---|---|---|---|
Net income 2022 | -2.03B -24.39M -1.92B | Net income 2023 | -2.23B -26.69M -2.11B | EV / Sales 2022 | 59.3 x |
Net Debt 2022 | 663M 7.95M 627M | Net cash position 2023 | 3.87B 46.38M 3.66B | EV / Sales 2023 | 22.8 x |
P/E ratio 2022 |
-38.4
x | P/E ratio 2023 |
-22.9
x | Employees | 407 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 25.38% |
Latest transcript on Sun Pharma Advanced Research Company Limited
1 day | -0.91% | ||
1 week | +3.40% | ||
Current month | -6.41% | ||
1 month | -46.75% | ||
3 months | -36.40% | ||
6 months | -16.16% | ||
Current year | -24.20% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 23/04/14 | |
Chetan Rajpara
DFI | Director of Finance/CFO | - | 31/01/17 |
Chairman | 68 | 28/02/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 28/02/06 | |
Director/Board Member | 67 | 28/02/06 | |
Director/Board Member | 70 | 30/10/14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 112 M€ | +5.59% | - | |
0.00% | 34 M€ | +4.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
15/05/24 | 217.4 | -0.91% | 522 641 |
14/05/24 | 219.4 | +2.26% | 1,295,655 |
13/05/24 | 214.6 | -2.03% | 613,196 |
10/05/24 | 219 | +3.23% | 772,695 |
09/05/24 | 212.2 | -3.70% | 2,222,178 |
Delayed Quote NSE India S.E., May 15, 2024 at 12:43 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-24.20% | 853M | |
+31.37% | 588B | |
-2.69% | 364B | |
+20.66% | 326B | |
+5.73% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.13% | 167B | |
0.00% | 161B |
- Stock Market
- Equities
- SPARC Stock